Ferring Pharmaceuticals Inc.
GPTKB entity
Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Per_Falk
|
| gptkbp:focusesOn |
endocrinology
gastroenterology maternal health reproductive medicine urology |
| gptkbp:foundedBy |
gptkb:Frederik_Paulsen
|
| gptkbp:foundedYear |
1950
|
| gptkbp:headquartersLocation |
gptkb:Saint-Prex,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ferring Pharmaceuticals Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:numberOfEmployees |
over 6,000
|
| gptkbp:operatesIn |
global
|
| gptkbp:parentCompany |
gptkb:Ferring_Holding_SA
|
| gptkbp:product |
gptkb:Desmopressin
gptkb:Firmagon gptkb:Menopur gptkb:Minirin gptkb:Pentasa gptkb:Rekovelle |
| gptkbp:subsidiary |
gptkb:Ferring_Holding_SA
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.ferring.com/
|
| gptkbp:bfsParent |
gptkb:Ferring
|
| gptkbp:bfsLayer |
7
|